- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
N-acetylcysteine promising nutritional supplement for women with PCOS
Previous research has mentioned that Metabolic syndrome affects 33% of women with polycystic ovary syndrome (PCOS). Emerging evidence suggests that N-acetylcysteine (NAC) improves metabolic parameters in PCOS and may be a potential alternative to metformin.
A recent study published in Frontiers in Nutrition has concluded that N-acetylcysteine (NAC) effectively improves metabolic parameters in PCOS. This study highlights NAC to be a potent supplement in managing PCOS.
PCOS is a common endocrine disease. Metabolic disorders often accompany this hormonal condition. To improve the metabolic function of PCOS, Metformin is widely used. This insulin sensitizer may have gastrointestinal side effects.
In this study, researchers searched four online databases: PubMed, Embase, Web of Science, and Cochrane Library. The I statistic and Cochrane's Q test were used to determine heterogeneity between studies with a value >50% or p < 0.1 considered significant. The data were expressed as standardized mean differences and 95% confidence intervals.
Key findings of this study are:
- The final analysis had 11 randomized controlled trials, including 869 women with PCOS.
- NAC caused more changes in body mass index, body weight, fasting insulin, the ratio of fasting blood glucose to fasting insulin, total cholesterol, triglycerides and low-density lipoprotein with -0.16, -0.25, -0.24,-0.38, -0.11,-0.18 -0.09, respectively compared with metformin.
- Compared with metformin or placebo, NAC significantly reduced fasting blood glucose levels.
- NAC reduced total cholesterol when compared with placebo.
- NAC reduced HDL levels in women with PCOS compared with metformin with SMD of -0.14.
Dr Liu J from The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China, said, In this study, we found that NAC is efficacious in improving metabolic parameters in PCOS. Based on the study findings, it is a promising nutritional supplement for treating PCOS.
Reference:
Liu, Jiajun, et al. "The Effects of N-acetylcysteine Supplement On Metabolic Parameters in Women With Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis." Frontiers in Nutrition, vol. 10, 2023, p. 1209614.
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751